Annualized height velocity of 9.05 cm/year (LS mean) for TransCon hGH-treated children was similar at Week 52 to daily somatropin-treated ...

However, in indoor environments, non-line-of-sight (NLOS) signals significantly degrade the ranging performance of UWB ...

Annualized height velocity of 9.05 cm/year (LS mean) for TransCon hGH-treated children was similar at Week 52 to daily somatropin-treated children - TransCon hGH showed a safety and tolerability profi ...

Treatment with TransCon CNP demonstrated continued improvement in observed change from baseline in upper-to-lower body segment ratio during the second year, from -0.04 at Week 52 to -0.10 at Week 104.

With the VLE, Mercedes-Benz Vans is launching the successor to the EQV while simultaneously debuting its new electric van ...

If you did not follow the action via the Solo reporting WhatsApp group then this report, embellished with exaggerations and imagination will try and do justice to the event.

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Welcome to InPost Fourth Quarter and Full Year 2025 Earnings Call. A usual disclaimer, today's call includes forward-looking statements that are subject to risks, and it is possible that the actual ...

The theme for the day is Innovation at Scale, Value that Endures. We spent a lot of time thinking about those 6 words over the last few months. And I hope by the end of the day, they resonate with you ...

The war is not only about regime change in Iran, ending its nuclear ambition and ballistic missile programme, and permanently debilitating Israel’s arch-enemy ...